Follow the 동국제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 동국제약 has logged 21 reports. The latest transaction was filed on 26 May 2026 (Sale). Among the most active insiders: 브이아이피자산운용. All data is accessible without an account.
21
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
14 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.